Patent details

EP3516060 Title: ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE

Basic Information

Publication number:
EP3516060
PCT Application Number:
EP2017074133
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177810306
PCT Publication Number:
WO2018055134
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
French Title of Invention:
OLIGONUCLÉOTIDES ANTISENS POUR LE TRAITEMENT DE MALADIES OCULAIRES
German Title of Invention:
ANTISENSE-OLIGONUKLEOTIDE ZUR BEHANDLUNG VON AUGENERKRANKUNGEN
SPC Number:

Dates

Filing date:
22/09/2017
Grant date:
21/07/2021
EP Publication Date:
31/07/2019
PCT Publication Date:
29/03/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2021
EP B1 Publication Date:
21/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/07/2021
 
 

Name:
ProQR Therapeutics II B.V.
Address:
Zernikedreef 9, 2333 CK Leiden, Netherlands (NL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/07/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CHAN, Hee Lam
Address:
Netherlands (NL)

2

Name:
TURUNEN, Janne Juha
Address:
Netherlands (NL)

3

Name:
VAN DIEPEN, Hester Catharina
Address:
Netherlands (NL)

Priority

Priority Number:
201616202
Priority Date:
23/09/2016
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
C12N 15/113; A61K 31/7088; A61K 31/712; A61P 27/02;

Publication

European Patent Bulletin

1

Issue number:
202129
Publication date:
21/07/2021
Description:
Grant (B1)

2

Issue number:
202133
Publication date:
18/08/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/08/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
ACUMASS SARL
Filing date Document type Number of pages
26/07/2021 Outgoing Correspondence 1
26/07/2021 Power Of Attorney 1